Pharm’image will attend the annual meeting of the EANM. Dusseldorf, Germany, October 13-17, 2017. Meet us at the booth of our member, Chematech (#63). During this major congress, scientific e-posters and oral presentations will be presented on innovative R&D projects in which Pharm’image and its members are actively involved.
Join an interactive pharmaco-imaging workshop on Magnetic Resonance & PET preclinical imaging! Workshop will go through therapeutic areas such as: > Oncology, > Cardiology, > Neurology, > Multimodality tracers. If you are looking for both PET/MR demonstrations & roundtables to exchange with experts, save the date and join in! Preclinical PET-MR workshop program […]
The first digital Positron Emission Tomography combined with a Computed Tomography (PET/CT) in France has been installed in the Centre Georges François Leclerc (CGFL) in Dijon. This cutting-edge system developed by General Electric Healthcare (GE Healthcare) was funded jointly by Dijon University Hospital and CGFL. Dijon University Hospital and CGFL, both profoundly attached to public […]
Pharm’image will be at the 30th annual meeting of the EANM Vienna, Austria, October 21-25, 2017 Meet us at the booths 2 of our members, Chematech (#259 ) and Cyclopharma (#210) During this major congress, scientific e-posters and oral presentations will be presented on innovative R&D projects in which Pharm’image and its members are […]
Last step of the IMAPPI project (reference ANR-10-EQPX-05-01/IMAPPI Equipex), one of the first integrated PET-MRI system in Europe has just been installed on the Pharm’image preclinical imaging platform at the CGFL. Started in 2012, IMAPPI program allowed to validate a first prototype of PET-MRI installed in parallel (2012-2014). Then an in-line system was developped (2014-2016), which […]
CheMatech, member of Pharm’Image, will be present at the World Molecular Imaging Congress 2017 in Philadelphia, from the 13th to 16th of September 2017. We will be very glad to welcome you booth #520 and to present you our new bifunctional chelating agents and imaging probes!
The scientific teams of Oncodesign, Cyclopharma, and their collaborators within the IMAkinib® program published recently their results during international meetings. These poster publications presented the synthesis of a radiotracer targeting the EGFR kinase, and the preclinical development of the molecule: European Association of Nuclear Medicine (EANM, October 2018, Dusseldorf, Germany) Phase 0/1 of PET […]
Scientific excellence of Pharm’image members was well represented at the last congress of (European Association of Nuclear Medicine, Barcelona October 2016) with the 7 oral communications and 4 posters. Two of our members, Chematech and Cyclopharma, were also present on their respective booths Oral communications: Initial performance evaluation of a preclinical PET scanner available as a […]